The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice.
Haematologica
; 108(5): 1322-1334, 2023 05 01.
Article
in En
| MEDLINE
| ID: mdl-36655430
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hemostatics
/
Hemophilia A
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Haematologica
Year:
2023
Document type:
Article